Cargando…

Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections

The recent spread of Zika virus (ZIKV) in the Americas and Asia necessitates an increased preparedness for improved maternal and perinatal health and blood safety. However, serological cross-reactions, especially to Dengue virus (DENV), complicate ZIKV antibody serodiagnosis. A novel “pan-Flavi” sus...

Descripción completa

Detalles Bibliográficos
Autores principales: Rönnberg, Bengt, Gustafsson, Åke, Vapalahti, Olli, Emmerich, Petra, Lundkvist, Åke, Schmidt-Chanasit, Jonas, Blomberg, Jonas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599479/
https://www.ncbi.nlm.nih.gov/pubmed/28852878
http://dx.doi.org/10.1007/s00430-017-0517-y
_version_ 1783264065776254976
author Rönnberg, Bengt
Gustafsson, Åke
Vapalahti, Olli
Emmerich, Petra
Lundkvist, Åke
Schmidt-Chanasit, Jonas
Blomberg, Jonas
author_facet Rönnberg, Bengt
Gustafsson, Åke
Vapalahti, Olli
Emmerich, Petra
Lundkvist, Åke
Schmidt-Chanasit, Jonas
Blomberg, Jonas
author_sort Rönnberg, Bengt
collection PubMed
description The recent spread of Zika virus (ZIKV) in the Americas and Asia necessitates an increased preparedness for improved maternal and perinatal health and blood safety. However, serological cross-reactions, especially to Dengue virus (DENV), complicate ZIKV antibody serodiagnosis. A novel “pan-Flavi” suspension multiplex immunoassay (PFSMIA) using 25 antigens, whole virus (WV), non-structural protein 1 (NS1), and envelope (E) proteins, from 7 zoonotic flaviviruses for specific detection of ZIKV and DENV IgM and IgG was developed. Patterns of antibody cross-reactivity, avidity, and kinetics were established in 104 sera from returning travelers with known ZIKV and DENV infections. PFSMIA gave IgM- and IgG-sensitivities for both viruses of 96–100%, compared to an immunofluorescence assay. Main IgM cross-reactions were to NS1, for IgG to the E and WV antigens. Infecting virus yielded reactivity to several antigens of the homologous virus, while cross-reactions tended to occur only to a single antigen from heterologous virus(es). A specificity-enhancing computer procedure took into account antibody isotype, number of antibody-reactive antigens per virus, avidity, average degree of cross-reactivity to heterologous flavivirus antigens, and reactivity changes in serial sera. It classified all 50 cases correctly. Applied to sera from 200 pregnant women and 173 blood donors from Sweden, one blood donor was found ZIKV NS1 IgM positive, and another as ZIKV NS1 IgG positive. These samples did not react with other ZIKV antigens and were thereby judged as false-positives. PFSMIA provided sensitive and specific ZIKV and DENV serology, warranting high-throughput serological surveillance and a minimized need for laborious and expensive virus neutralization assays. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00430-017-0517-y) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5599479
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-55994792017-10-03 Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections Rönnberg, Bengt Gustafsson, Åke Vapalahti, Olli Emmerich, Petra Lundkvist, Åke Schmidt-Chanasit, Jonas Blomberg, Jonas Med Microbiol Immunol Original Investigation The recent spread of Zika virus (ZIKV) in the Americas and Asia necessitates an increased preparedness for improved maternal and perinatal health and blood safety. However, serological cross-reactions, especially to Dengue virus (DENV), complicate ZIKV antibody serodiagnosis. A novel “pan-Flavi” suspension multiplex immunoassay (PFSMIA) using 25 antigens, whole virus (WV), non-structural protein 1 (NS1), and envelope (E) proteins, from 7 zoonotic flaviviruses for specific detection of ZIKV and DENV IgM and IgG was developed. Patterns of antibody cross-reactivity, avidity, and kinetics were established in 104 sera from returning travelers with known ZIKV and DENV infections. PFSMIA gave IgM- and IgG-sensitivities for both viruses of 96–100%, compared to an immunofluorescence assay. Main IgM cross-reactions were to NS1, for IgG to the E and WV antigens. Infecting virus yielded reactivity to several antigens of the homologous virus, while cross-reactions tended to occur only to a single antigen from heterologous virus(es). A specificity-enhancing computer procedure took into account antibody isotype, number of antibody-reactive antigens per virus, avidity, average degree of cross-reactivity to heterologous flavivirus antigens, and reactivity changes in serial sera. It classified all 50 cases correctly. Applied to sera from 200 pregnant women and 173 blood donors from Sweden, one blood donor was found ZIKV NS1 IgM positive, and another as ZIKV NS1 IgG positive. These samples did not react with other ZIKV antigens and were thereby judged as false-positives. PFSMIA provided sensitive and specific ZIKV and DENV serology, warranting high-throughput serological surveillance and a minimized need for laborious and expensive virus neutralization assays. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00430-017-0517-y) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-08-29 2017 /pmc/articles/PMC5599479/ /pubmed/28852878 http://dx.doi.org/10.1007/s00430-017-0517-y Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Original Investigation
Rönnberg, Bengt
Gustafsson, Åke
Vapalahti, Olli
Emmerich, Petra
Lundkvist, Åke
Schmidt-Chanasit, Jonas
Blomberg, Jonas
Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections
title Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections
title_full Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections
title_fullStr Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections
title_full_unstemmed Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections
title_short Compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of Zika versus other flavivirus infections
title_sort compensating for cross-reactions using avidity and computation in a suspension multiplex immunoassay for serotyping of zika versus other flavivirus infections
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5599479/
https://www.ncbi.nlm.nih.gov/pubmed/28852878
http://dx.doi.org/10.1007/s00430-017-0517-y
work_keys_str_mv AT ronnbergbengt compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections
AT gustafssonake compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections
AT vapalahtiolli compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections
AT emmerichpetra compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections
AT lundkvistake compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections
AT schmidtchanasitjonas compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections
AT blombergjonas compensatingforcrossreactionsusingavidityandcomputationinasuspensionmultipleximmunoassayforserotypingofzikaversusotherflavivirusinfections